New genetic therapy holds promise for ALS and frontotemporal dementia
Neuroscientists have developed a single-dose genetic medicine that has been proven to halt the progression of both ALS and FTD in mice — and may even offer the potential to reverse some of the effects of the fatal diseases. It may also hold opportunit…